Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A27013 | 19355912 | Curr Mol Med | Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. | 2009 | Details |
A27014 | 19353360 | Ann Med | New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). | 2009 | Details |
A27015 | 19352614 | J Mol Med (Berl) | Molecular mechanisms involved in NAFLD progression. | 2009 | Details |
A27016 | 19352053 | Endocr J | Increased liver enzymes in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. | 2009 | Details |
A27019 | 19337636 | J Gastrointestin Liver Dis | Perihepatic adipose tissue thickness: a new non-invasive marker of NAFLD? | 2009 | Details |
A27020 | 19337018 | J Endocrinol Invest | Relationship between cerebral arterial pulsatility and carotid intima media thickness in diabetic and non-diabetic patients with non-alcoholic fatty liver disease. | 2009 | Details |
A27022 | 23105825 | Indian J Clin Biochem | Clinicopathological spectrum of non-alcoholic fatty liver disease among patients in Kerala. | 2009 | Details |
A27023 | 21495339 | Rev Med Chir Soc Med Nat Iasi | [Adipocytokines and nonalcoholic steatohepatitis]. | 2011 | Details |
A27024 | 19330863 | Hepatology | Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. | 2009 | Details |
A27026 | 19323780 | Liver Int | Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease. | 2009 | Details |
A27027 | 19321579 | J Nutr | Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. | 2009 | Details |
A27029 | 19318971 | Eur J Gastroenterol Hepatol | Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. | 2009 | Details |
A27030 | 19317274 | Acta Gastroenterol Belg | Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis. | 2009 | Details |
A27031 | 19303656 | J Hepatol | HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: a novel mechanism for NAFLD. | 2009 | Details |
A27032 | 19302184 | Liver Int | Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease. | 2009 | Details |
A27033 | 19301078 | Obes Surg | Lipoprotein lipase expression in livers of morbidly obese patients could be responsible for liver steatosis. | 2009 | Details |
A27034 | 19299029 | J Hepatol | Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. | 2009 | Details |
A27035 | 19293782 | Am J Gastroenterol | NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. | 2009 | Details |
A27037 | 19291785 | Hepatology | Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. | 2009 | Details |
A27038 | 19291292 | J Inflamm (Lond) | Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? | 2009 | Details |
A27039 | 19291181 | Liver Int | Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease. | 2009 | Details |
A27040 | 19290887 | FEBS J | Full-length adiponectin protects hepatocytes from palmitate-induced apoptosis via inhibition of c-Jun NH2 terminal kinase. | 2009 | Details |
A27041 | 19289381 | Gut | The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection. | 2009 | Details |
A27042 | 19285022 | Biochem Biophys Res Commun | The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis. | 2009 | Details |
A27043 | 19285015 | Biochem Biophys Res Commun | Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway. | 2009 | Details |
A27044 | 19282820 | Obesity (Silver Spring) | Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55. | 2009 | Details |
A27045 | 19282764 | Eur J Gastroenterol Hepatol | Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels. | 2009 | Details |
A27046 | 19280268 | Obes Surg | Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis. | 2009 | Details |
A27047 | 19278843 | Nutr Metab Cardiovasc Dis | Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. | 2009 | Details |
A27048 | 19271113 | J Gastroenterol | High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population. | 2009 | Details |
A27049 | 19269347 | Biochim Biophys Acta | In vivo assessment of hepatic triglycerides in murine non-alcoholic fatty liver disease using magnetic resonance spectroscopy. | 2009 | Details |
A27050 | 19268270 | Clin Gastroenterol Hepatol | Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. | 2009 | Details |
A27051 | 19267193 | Dig Dis Sci | Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation. | 2009 | Details |
A27052 | 19266602 | World J Gastroenterol | Liver histology according to the presence of metabolic syndrome in nonalcoholic fatty liver disease cases. | 2009 | Details |
A27053 | 19261002 | Hepatol Res | Role of hepatic iron in non-alcoholic steatohepatitis. | 2009 | Details |
A27054 | 19254570 | Cell Metab | The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. | 2009 | Details |
A27056 | 19254460 | Zhonghua Gan Zang Bing Za Zhi | [Abdominal adipose area, serum adiponectin and leptin levels of nonalcoholic fatty liver disease in elderly males.]. | 2009 | Details |
A27057 | 23396636 | J Ultrasound | Nonalcoholic fatty liver disease (NAFLD) in nonobese patients with diabetes: Prevalence and relationships with hemodynamic alterations detected with Doppler sonography(). | 2009 | Details |
A27058 | 19246975 | J Endocrinol Invest | Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population. | 2008 | Details |
A27059 | 19245356 | Womens Health (Lond) | Nonalcoholic fatty liver disease in women. | 2009 | Details |
A27060 | 19243311 | Clin Sci (Lond) | Metabolic disturbances in non-alcoholic fatty liver disease. | 2009 | Details |
A27061 | 19242728 | Pediatr Nephrol | Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease. | 2009 | Details |
A27062 | 19240815 | Hippokratia | Non alcoholic fatty liver disease and metabolic syndrome. | 2009 | Details |
A27063 | 19231016 | J Hepatol | Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. | 2009 | Details |
A27064 | 19231010 | J Hepatol | Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. | 2009 | Details |
A27065 | 19230890 | Atherosclerosis | Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model. | 2009 | Details |
A27066 | 19187068 | Liver Int | Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response. | 2009 | Details |
A27067 | 19226377 | J Gastroenterol Hepatol | Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. | 2008 | Details |
A27068 | 19225402 | J Acquir Immune Defic Syndr | Nonalcoholic fatty liver disease among HIV-infected persons. | 2009 | Details |
A27069 | 19224892 | Arch Dis Child | Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study. | 2009 | Details |
A27070 | 19148801 | J Gastroenterol | The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. | 2009 | Details |
A27071 | 19223453 | Bioinformatics | A new ensemble-based algorithm for identifying breath gas marker candidates in liver disease using ion molecule reaction mass spectrometry. | 2009 | Details |
A27072 | 19223251 | Dig Liver Dis | Non-alcoholic fatty liver disease pathogenesis: the present and the future. | 2009 | Details |
A27073 | 19222849 | BMC Gastroenterol | Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study. | 2009 | Details |
A27074 | 19222113 | Am J Chin Med | Therapeutic effect of puerarin on non-alcoholic rat fatty liver by improving leptin signal transduction through JAK2/STAT3 pathways. | 2009 | Details |
A27075 | 19221674 | Ann Acad Med Singap | Consequences of childhood obesity. | 2009 | Details |
A27076 | 19221666 | Ann Acad Med Singap | The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents. | 2009 | Details |
A27077 | 19221529 | Ann Hepatol | Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). | 2009 | Details |
A27078 | 19221528 | Ann Hepatol | Hepatogenous diabetes. Current views of an ancient problem. | 2009 | Details |
A27079 | 19221054 | Radiology | Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. | 2009 | Details |
A27080 | 19220207 | Aliment Pharmacol Ther | Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians. | 2009 | Details |
A27081 | 19217891 | Clin Biochem | Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease. | 2009 | Details |
A27082 | 19215335 | J Gastroenterol Hepatol | An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. | 2009 | Details |
A27083 | 19214773 | J Inherit Metab Dis | Combined hyperlipidaemia as a presenting sign of cholesteryl ester storage disease. | 2009 | Details |
A27084 | 19214024 | Am J Med Sci | Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans. | 2009 | Details |
A27085 | 19208353 | Gastroenterology | Heritability of nonalcoholic fatty liver disease. | 2009 | Details |
A27086 | 19202511 | Pediatr Endocrinol Rev | Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. | 2008 | Details |
A27087 | 19199918 | Curr Med Chem | Obesity: pathophysiology and clinical management. | 2009 | Details |
A27088 | 19195631 | Diabetes Metab | The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis. | 2008 | Details |
A27089 | 19195630 | Diabetes Metab | Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis. | 2008 | Details |
A27090 | 19195629 | Diabetes Metab | Non-invasive diagnosis of steatosis and fibrosis. | 2008 | Details |
A27091 | 19195628 | Diabetes Metab | How to measure hepatic insulin resistance? | 2008 | Details |
A27092 | 19195627 | Diabetes Metab | Adipose tissue inflammation and liver pathology in human obesity. | 2008 | Details |
A27093 | 19195625 | Diabetes Metab | The role of the lipogenic pathway in the development of hepatic steatosis. | 2008 | Details |
A27094 | 19195624 | Diabetes Metab | Definition and natural history of metabolic steatosis: histology and cellular aspects. | 2008 | Details |
A27095 | 19195623 | Diabetes Metab | Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. | 2008 | Details |
A27096 | 19194305 | Eur J Gastroenterol Hepatol | Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients. | 2009 | Details |
A27097 | 19184102 | Eur J Pediatr | Nonalcoholic fatty liver disease during valproate therapy. | 2009 | Details |
A27098 | 19183714 | Paediatr Child Health | Anthropometric and metabolic characteristics in children with clinically diagnosed nonalcoholic fatty liver disease. | 2008 | Details |
A27099 | 19181602 | J Formos Med Assoc | Non-alcoholic steatohepatitis: an overview. | 2009 | Details |
A27100 | 19177596 | Hepatology | Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice. | 2009 | Details |
A27101 | 19174415 | Gut | Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH. | 2009 | Details |
A27102 | 19171337 | Fertil Steril | Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome. | 2009 | Details |
A27103 | 19168251 | Diabetes Res Clin Pract | Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. | 2009 | Details |
A27104 | 19166967 | Biochim Biophys Acta | Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity. | 2009 | Details |
A27105 | 19166659 | Curr Gastroenterol Rep | Nonalcoholic fatty liver disease and cardiovascular risk. | 2009 | Details |
A27106 | 19165171 | Obesity (Silver Spring) | Liver NF-kappaB and AP-1 DNA binding in obese patients. | 2009 | Details |
A27107 | 19162235 | Clin Gastroenterol Hepatol | Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. | 2008 | Details |
A27109 | 19159884 | Atherosclerosis | Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans. | 2008 | Details |
A27110 | 19155640 | Turk Kardiyol Dern Ars | The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome. | 2008 | Details |
A27111 | 19155426 | J Am Coll Nutr | Nonalcoholic fatty liver disease in children. | 2008 | Details |
A27112 | 19155086 | J Hepatol | Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests. | 2008 | Details |
A27113 | 19152453 | World J Gastroenterol | Nonalcoholic fatty liver disease in asymptomatic Brazilian adolescents. | 2009 | Details |
A27114 | 19147984 | J Clin Invest | Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. | 2009 | Details |
A27115 | 19144866 | Exp Biol Med (Maywood) | Fatty acid composition and development of hepatic lipidosis during food deprivation--mustelids as a potential animal model for liver steatosis. | 2009 | Details |
A27116 | 19142989 | Hepatology | Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. | 2009 | Details |
A27117 | 19141695 | Am J Clin Nutr | Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver. | 2009 | Details |
A27118 | 19140676 | J Proteome Res | Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis. | 2009 | Details |
A27119 | 19140227 | World J Gastroenterol | Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. | 2009 | Details |
A27120 | 19137965 | Ned Tijdschr Geneeskd | [Summary of the practice guideline 'Viral hepatitis and other liver diseases' (second revision) from the Dutch College of General Practitioners]. | 2008 | Details |